Pralidoxime Chloride Injection is a vital antidote used in the management of organophosphate pesticide or nerve agent poisoning. It works by reactivating cholinesterase enzymes that become inhibited due to toxic exposure, helping reverse muscle weakness, respiratory depression, and neuromuscular paralysis. Used alongside atropine, it forms a key component of emergency and critical care treatment protocols in hospitals and field settings. Its rapid onset and proven efficacy make it essential in toxicology, emergency medicine, and industrial safety preparedness. Manufactured under stringent pharmaceutical quality standards, Pralidoxime Chloride Injection ensures dependable, fast-acting therapeutic support during life-threatening poisoning events.
AOPP-500-Pralidoxime Chloride Injection IP 500mg
Pralidoxime Chloride Injection is an antidote used to treat organophosphate poisoning. It helps restore normal nerve function by reactivating cholinesterase, providing rapid, life-saving support in emergencies.
Brand Name: AOPP-500
Generic Name: Pralidoxime Chloride Injection
Available Strengths:
Pralidoxime Chloride Injection IP 500mg
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com